A European specialist investor in global healthcare has invested in Sapio Sciences (Sapio), an integrated lab informatics platform with offices in York.
Global Healthcare Opportunities, or GHO Capital Partners LLP, announced Thursday that it has invested in Sapio, which is helping to transform and accelerate life science research and development for international biopharmaceutical companies and clinical diagnostic labs.
Based in Pennsylvania, Sapio serves an international customer base throughout the United States with additional footholds in Europe and Japan, and ambitions to expand globally in the coming years, GHO said.
Founded in 2004 by Chief Scientist and CEO Kevin Cramer, Sapio has established a highly scalable technology solution addressing the Laboratory Information Management (LIMS), Electronic Laboratory Notebooks (ELN) and Scientific Data Management (SDMS) markets with its unified lowcode, no-code platform.
Sapio’s clinical LIMS offers complete end to end operational support for molecular diagnostic labs including a physician portal for test ordering, kit management, sample shipment and accessioning, order transcription to lab processing and patient reporting in a seamless solution, GHO said.
As regulators and customers continue to place greater emphasis on data quality, data access, and AL/ML, Sapio’s informatics platform easily captures and centralizes scientific and process data, which is currently siloed in different systems, while making it easily searchable and usable across all workstreams and speeding up drug development, GHO said.
With its customer base that includes Bristol Myers Squibb, GSK, J&J, Charles River and LabCorp, Sapio is set to continue driving growth in the lab informatics and drug development landscape.
GHO said its support and investment will allow Sapio to explore multiple avenues for growth and expansion for the company, product offering and global footprint.
“The trend towards adopting lab informatics solutions is accelerating. Sapio represents a perfect opportunity to support a high growth, profitable company with a uniquely scalable SaaS business model, operating in attractive markets that are underpenetrated and desperate for innovation,” the partners at GHO said. “Working in lockstep with Kevin, we look forward to building upon Sapio’s best-in-class profile and unlocking the multiple expansion opportunities to scale up and internationalize the business, delivering life-changing products to market faster.”
Sapio’s Cramer said, “As lab workflows become increasingly complex and the volume of data increases, the management and interrogation of that data becomes even more vital. Over the last eighteen years, Sapio has built a uniquely flexible, scalable, unified and easy-to-use informatics platform developed specifically to address the deficiencies of current processes. We are proud to have GHO partner with us to support our next transformational steps as a company.”